Providing a scientific forum for practical applications and theoretical advances of Artificial Intelligence (AI) in the life sciences and related disciplines including (but not restricted to):New AI methods for life science researchAdaptation of existing AI concepts for life science applicationsApplication of AI approaches in: Molecular and systems biologyPopulation and disease geneticsBio- and cheminformaticsMedicinal chemistry, chemical biology, and drug discoveryMedical researchPublications are required to contain substantial AI and life science components. Clinical studies reporting routine diagnostic efforts hall outside the scope of AILSCI.Background: Artificial Intelligence originates from computer science and covers a wide range of approaches intended to enhance the ability of machines to make data-driven decisions and accurate predictions of events. In many scientific fields, AI is being increasingly considered and integrated, especially in the context of Big Data. Given their complexity and highly interdisciplinary nature, the life sciences provide ample opportunities for AI to impact R&D efforts in a variety of ways.Key words: Artificial Intelligence; Life Sciences; Drug Discovery; Bio- and Cheminformatics, Machine Learning; Machine Intelligence; Deep Learning; Data Mining; Big Data.
ESMO Real-World Data and Digital Oncology is the European Society for Medical Oncology's latest peer-reviewed open access journal. It is dedicated to publishing high-quality data science and educational content on the transformation of oncology care with real-world evidence and digital technologies that physicians can trust and understand.The journal will publish innovative research that provides actionable insights from real-world data sources and digital devices, such as generalizable observational and health services research, clinical informatics solutions, algorithm-powered diagnostics, and decision support systems and direct-to-patient mobile applications.Main focuses of interest include: disease characterization, rare and under-represented populations in clinical trials, head-to-head comparative effectiveness, unmet needs and gaps in access or care delivery, resource utilization and heath economics, post-marketing treatment optimization and tolerability and patients' outcomes and preferences. In addition, studies that evaluate the net benefit of incorporating artificial intelligence applications in clinical practice, or explore how the human aspect of medicine, relations between patient and physician, may be affected by the increasing use of technology in routine practice.With an international editorial board of experts and key opinion leaders, the journal will support multiple stakeholders as they engage with digital solutions and information systems to solve complex cancer problems. Providing essential reading for all stakeholders we will publish original research, reviews, editorials, perspectives, correspondence, and news.The journal will provide balanced implementation guidance, training, and resources to ensure appropriate use of real-world data and digital technologies, at the highest methodological standards.ESMO Real-World Data and Digital Oncology aims to operate a fast submission process with continuous publication online, to ensure that timely, up-to-date research is available worldwide and adheres to a rigorous and transparent peer review process.
Heliyon considers research from all areas of the physical, applied, life, social and medical sciences. We publish manuscripts reporting scientifically accurate and valuable research, which adheres to accepted ethical and scientific publishing standards. As such Heliyon publishes new insights as well as extensions on existing theories, negative/null results and replication studies.Submissions covering arts, humanities and law are not considered in Heliyon. Authors of these submissions are encouraged to submit directly to our partner journal Social Sciences & Humanities Open.Heliyon classifies manuscripts/articles into different sections based on the research topic discussed. Some sections exclude certain types of studies from their scope. To know more and to see the kind of manuscripts the various sections publish, please visit: https://www.cell.com/heliyon/sectionsA dedicated in-house editorial office team, internal editors as well as external academic section and associate editors handle your manuscript and manage the publication process, giving your research the editorial support and quality control it deserves.If it's important to you, it's important to us. Submit your paper today.